SPOREGEN LIMITED is a biotechnology company based at The London BioScience Innovation Centre (LBIC) in London.

SPOREGEN is focused on four areas.

1. Clostridium difficile: we have developed a unique prophylactic and therapeutic approach for C. difficile infection.

2. Probiotics: we identify and develop Bacillus, heat stable, spore probiotic formulations. This includes progression to GRAS status and a number of these have now been licenced including HU58 and HU36.

3. Prophylactic approaches to COVID-19 including SPOR-COV, a unique mucosal immune modulator, and SPORCOVAX, a mucosal vaccine.

4. Contracts: focusing primarily on in vivo evaluations of C. difficile interventions.

Biotechnology

SPOREGEN LIMITED

SPOREGEN LIMITED's headquarters in London, United Kingdom

SPOREGEN LIMITED

Org chart

Teams

Offices

SPOREGEN LIMITED

Org chart

Teams

Offices

Related companies